As per the scheme, SRL (Fortis Healthcare's business engaged in diagnostics) will be merged with Fortis Malar in the first step. Subsequently, the name of Fortis Malar will be changed to SRL BS B2B Bureau | Gurgaon August 20, 2016 Last Updated at 13:11 IST ... Business Standard, 1 week ago
Fortis to get a makeover, demerge diagnostics business - Money Control, 1 week ago
Fortis Health approves demerger of its diagnostics business - Money Control, 1 week ago
Registers 26 per cent increase in number of samples received for the disease SRL Diagnostics has released a report on celiac disease (CD) at pan India level. The data reveals that there has been a 26 per cent increase in the number of samples ...Financial Express, 1 month ago 26 per cent increase in celiac disease related samples in the country: SRL Report PharmaBiz, 1 month ago 26% Increase in Celiac Disease Related Samples: SRL Report Pocket News Alert.com, 1 month ago 1 out of 4 Indians found having abnormal Thyroid level: Study India Blooms, 2 months ago
-Test to detect stress level, respiratory diseases and lead content in human body- - Priced at Rs. 4650, available in All Metropolitan Cities- Chandigarh, July 05, 2016: SRL Diagnostics, the leading diagnostic chain in India, has introduced an ...Pocket News Alert.com, 1 month ago SRL Diagnostics introduces test to detect stress level, respiratory diseases and lead content in human body PharmaBiz, 1 month ago
The company is expected to announce demerger details of SRL Diagnostics into a separate entity on August 19.India Infoline, 1 week ago Fortis likely to demerge SRL Diagnostics into separate co Money Control, 1 month ago
Fortis Healthcare shares surged as much as 5 per cent on Friday after the hospital chain decided to demerge its diagnostic division to raise up to Rs 5,000 crore. Fortis Healthcare in a release to Bombay Stock Exchange said its board of directors ...NDTV Profit, 3 weeks ago Fortis Malar Hospitals hits the roof Sify, 1 week ago Fortis Healthcare shares rise despite weak Q1 nos Economic Times, 3 weeks ago Fortis Healthcare shares gain despite 74% fall in Q1 net profit, here is why Financial Express, 3 weeks ago
June 23--MUMBAI -- Metropolis Healthcare Ltd, one of the three largest diagnostic chains in India, plans to sell shares in an initial public offering (IPO) to raise around Rs.1,000 crore, seeking to tap investor interest in the healthcare sector. ...Bloomberg, 2 months ago Metropolis Healthcare exits South Africa, rejigs Middle East business VC Circle, 2 weeks ago
TIZIANA LIFE SCIENCES : Acquires a Unique Bio-Repository From Shardna SpA and Establishes LonGevia Genomics Srl, a Sardinian Based Subsidiary to Further Enhance and...
Tiziana Acquires a Unique Bio-Repository From Shardna SpA and Establishes LonGevia Genomics Srl, a Sardinian Based Subsidiary to Further Enhance and Develop Its Portfolio By a News Reporter-Staff News Editor at Biotech Week -- Tiziana Life Sciences ...4 Traders, 1 month ago Tiziana Acquires a Unique Bio-Repository From Shardna SpA and Establishes LonGevia Genomics Srl, a Sardinian Based Subsidiary to Further Enhance and Develop Its Portfolio AndhraNews.net, 1 month ago Tiziana Life Sciences PLC Tiziana acquires a unique bio-repository ADVFN UK, 1 month ago Tiziana Life Sciences Plc Acquires A Unique Bio-Repository From And Establishes A Sardinian Based Subsidiary To Further Enhance And Develop Its Portfolio BioSpace, 1 month ago
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced today the acquisition of Space Import-Export Srl (Space) of Milan, Italy . Space is a long and trusted partner of Bio-Techne, distributing its products since 1985 and creating a very ...USA Life Sciences Database, 1 month ago Bio-Techne Acquires Space Import-Export And Strengthens European Leadership Team Ariva.de, 1 month ago BIO TECHNE : Acquires Space Import-Export And Strengthens European Leadership Team 4 Traders, 1 month ago Bio-techne makes push into genomics market with $250M ACD acquisition Medical Device Daily, 1 month ago
MGC Diagnostics Corporation Receives FDA 510(k) Clearance for Resmon PRO FULL, Forced Oscillation Technique (FOT) Device
SAINT PAUL, Minn. , June 28, 2016 /PRNewswire/ -- MGC Diagnostics Corporation ( NASDAQ: MGCD ), a global medical technology company, today announced that the U.S. Food and Drug Administration ("FDA") has granted 510(k) clearance for the Resmon PRO ...WorldNetDaily, 2 months ago 6/28/16 - MGC Diagnostics Corporation Receives FDA 510(k) Clearance for Resmon?¢ PRO FULL, Forced Oscillation Technique (FOT) Device Pharmacy Choice, 2 months ago
Key Players discussed in Report A2K Technologies,Abbott Diagnostics,Abcodia Ltd.,Acobiom,Advanced Marker Discovery, S.L.,Advpharma Inc.,Ambergen, Inc.,Ambrilia Biopharma Inc.,Arizona State University,ArtemixRx,Asuragen, Inc.,Bio Mark ...Before It's News, 2 weeks ago Ophthalmic Diagnostic Equipment Trends, Analysis and Forecast 2021 MyNewsDesk, 1 month ago Global Ophthalmic Diagnostic Devices Market Consumption to 2021, Trends, Forecasts and Key Companies are studied in a Latest Report Offered by The Market Reports MyNewsDesk, 1 month ago Report Analysis and Forecast on United States Ophthalmic Diagnostic Devices Industry 2016 MyNewsDesk, 1 month ago
on your WebpageAdd Widget >Get your members hooked!